News Releases - MedAvail

Year

August 30, 2023

MedAvail to Participate in H.C. Wainwright 25th Annual Global Investment Conference

PHOENIX , Aug. 30, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, announced today that Mark Doerr , Chief Executive Officer, will participate in H.C. Wainwright 25th Annual Global Investment Conference on Monday, September

August 14, 2023

MedAvail Reports Second Quarter 2023 Financial Results

PHOENIX , Aug. 14, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today reported financial results for the second quarter ended June 30, 2023 . “During the second quarter, we were able to sustain the positive momentum that we

August 4, 2023

MedAvail Announces Agreement with Dallas-Based Oak Lawn Pharmacy for Deployment of Ten M4 MedCenters

Oak Lawn Pharmacy to deploy two M4 kiosks in 2023, with the remaining units to be deployed within 24 months of contract execution PHOENIX , Aug. 04, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, announced today that it has

July 31, 2023

MedAvail Announces 1-for-50 Reverse Stock Split

PHOENIX, Ariz. , July 31, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail” or the “Company”), an innovative pharmacy technology company, announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-50.

July 13, 2023

MedAvail Announces Enhanced API Integration with its Largest Partner, Texas Health Resources

Integration allows for streamlined MedCenter deployments and an improved partner and patient experience PHOENIX, Ariz. , July 13, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, announced today it has successfully achieved

May 18, 2023

MedAvail Reports First Quarter 2023 Financial Results

PHOENIX , May 18, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today reported financial results for the first quarter ended March 31, 2023 . “During the first quarter, we made good progress toward our mission of becoming a

May 18, 2023

MedAvail to Report First Quarter 2023 Financial Results on May 18

Management to host investor conference call and webcast at 4:30pm EDT today PHOENIX , May 18, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today announced that the Company will announce financial results for the first

May 15, 2023

MedAvail Postpones Reporting of First Quarter 2023 Financial Results

PHOENIX , May 15, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (NASDAQ: MDVL) (“MedAvail” or the “Company”), an innovative pharmacy technology company, announced today that it is postponing its scheduled earnings release and conference call for the quarter ended March 31, 2023 previously

April 13, 2023

MedAvail Reports Fourth Quarter and Full-Year 2022 Financial Results

PHOENIX , April 13, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today reported financial results for the three months and full-year ended December 31, 2022 . “Since assuming the role of CEO in January 2022 , I have been

April 12, 2023

MedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on April 13

Management to host investor conference call and webcast at 4:30pm EDT on that day PHOENIX , April 12, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, today announced that the Company will announce financial results for the

Pagination

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 15